Skip to main navigation Skip to search Skip to main content

PECan study, imaging PD-L1 in cancer: A tool for measuring response to immunotherapy?

  • Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, People’s Republic of China Nanomab Technology Limited, Shanghai, People’s Republic of China
  • Nanomab Technology Limited, Shanghai, People’s Republic of China

Research output: Contribution to conference typesPosterpeer-review

Fingerprint

Dive into the research topics of 'PECan study, imaging PD-L1 in cancer: A tool for measuring response to immunotherapy?'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry